Synthesis of pyrrolo[2,3-d]pyrimidines (microreview)

Chemistry of Heterocyclic Compounds - Microreview summarizes recent methods for the synthesis of pyrrolo[2,3-d]pyrimidines, published since 2015. The methods are classified as Cu-catalyzed...     

Synthesis of pyrrolo[2,3-d]pyrimidine ribosides and their potential in chemotherapeutics

The synthesis of a number of 5,6-dimethylpyrrolo[2,3-d)pyrimidines substituted in position 7 with ribose, deoxyribose, respectively and their acyclic analogues is described and their potential in chemotherapeutics was tested. None of the compounds showed remarkable biological effects.     

Functionalization of pyrrolo[2,3-d]pyrimidine by palladium-catalyzed cross-coupling reactions (review)

Palladium-catalyzed cross-coupling reactions (Heck, Sonogashira, Stille, Suzuki) in the pyrrolo-[2,3-d]pyrimidine series with emphasis on synthesis of biologically active and functional materials are reviewed.     

4-氯-7H-吡咯并[2,3-d]嘧啶与2,4-二氯-7H-吡咯并[2,3-d]嘧啶的合成研究

报道了以廉价易得的丙二酸二乙酯为起始原料,经过α-烷基化、环合、氯化、烯键氧化和SNAr/环化五步反应,高收率地得到目标产物4-氯-7H-吡咯并[2,3-d]嘧啶(6)和2,4-二氯-7H-吡咯并[2,3-d]嘧啶(10)(总收率分别达到45.8%和44.8%)的合成方法,并对中间体和产物的化学结构进行了表征.     

Synthesis of 2-selenothieno[2,3-d]pyrimidine derivatives

Intramolecular cyclization of 2-(N-acylselenoureido)-3-carbethoxy-4,5,6,7-tetrahydrobenzo[b]thiophenes in alkaline media leads to the formation of the potassium salt (I) of 2-seleno-4-oxo-3,4,5,6,7,8-hexahydrobenzo[b]thieno[2,3-d]pyrimidine, acidification of which yielded the corresponding base in free form. Some pyrimidine compounds containing a selenium atom in the side chain were obtained by reaction of potassium salt I with halo derivatives (ClCH₂CH₂COOCH₃ and ClCH₂CH₂OH).Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 6, pp. 753–754, June, 1977.     

Synthesis of 2H-pyrano[2,3-d]pyrimidine derivatives

Two series of 2H-pyrano[2,3-d]pyrimidine-2,5(6H)-dione derivatives have been prepared. Thus, the reaction of 6-hydroxy-pyrimidin-4(3H)-ones (1 a–c) with bis-2,4,6-trichlorphenyl malonates (2 a–d) or diethyl malonates (3 a–d) afforded good yields of 4-hydroxy-2H-pyrano[2,3-d]pyrimidine-2,5(6H)-diones (4 a-l). Application of our modifiedPechmann reaction^9–11 using -aminocrotonate (5) or -keto esters (6, 7) in the presence of ammonium acetate yielded the 2H-pyrano[2,3-d]pyrimidinediones8 a–h.Dedicated to Prof. Dr.Karl Schlögl, University of Vienna, on the occasion of his 60th birthday.     

Synthesis of new pyrido[2,3-d]pyrimidine derivatives

The mutual condensation of 4-aminouracil or 2,4-diamino-6-hydroxypyrimidine with bisacetonitrile and aldehydes was used to synthesize 2,4-dioxo-5-R-7-methyl-6-cyano-1,2,3,4,5,8-hexahydropyrido[2,3-d]pyrimidine and 2-amino-4-oxo-5-R-7-methyl-6-cyano-3,4,5,8-tetrahydropyrido[2,3-d]pyrimidine derivatives, which were oxidized with chromic anhydride to the corresponding 2,4-dioxo-5-R-7-inethyl-6-eyano-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine and 2-amino-4-oxo-5-R-7-methyl-6-cyano-3,4-dihydro[2,3-d]pyrimidines. The IR and UV spectra of the synthesized compounds were recorded.Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 3, pp. 422–425, March, 1972.     

A study of electrophilic substitution in the pyrrolo[2,3-d]pyrimidine ring

Several 4,5-disubstituted pyrrolo[2,3-d ]pyrimidines were prepared for the first time via electrophilic substitution, e.g. halogenation, nitration and sulfonation. PMR data for certain pyrrolo[2,3-d]pyrimidines are included which has furnished conclusive evidence that electrophilic substitution occurred at position 5. These pyrrolo[2,3-d]pyrimidines, with electron -withdrawing substituents at position 5, are of considerable interest as bases for the preparation of nucleoside derivatives related to tubercidin, toyocamcin and sangivamycin.     

Pyrimidine derivatives. 57. New method for the synthesis of pyrrolo[2,3-d]pyrimidine

The action of bromine on 5-allyl-6-aminopyrimidines was studied. The formation of both a product of addition of bromine to the allylic bond and pyrrolo [2,3-d]-pyrimidines is possible, depending on the character of the substituent attached to the amino group. The structures of the synthesized compounds were confirmed by PMR and mass-spectrometric data.See [1] for Commication 56.Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 12, pp. 1686–1689, December, 1982.     

Synthesis of the pyrrolo[3,2-d]pyrimidine C-nucleoside isostere of inosine

The synthesis of “9-deazainosine,” a new C-nucleoside analog of inosine and of formycin B is described. It involves conversion of a ribosylated 3-amino-2-carboalkoxypyrrole intermediate to the desired pyrrolo[3,2-d]pyrimidine system.     

Pyrrolopyrimidine nucleosides. IV. The synthesis of certain 4,5-disubstituted-7-(β-d-ribofuranosyl)pyrrolo[2,3-d]pyrimidines related to the pyrrolo[2,3-d]pyrimidine nucleoside antibiotics

The treatment of 4-chloro-7-(2′,3′,5′-tri-O-acetyl-β-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine ( 4 ) with N-bromoacetamide in methylene chloride has furnished the 5-bromo derivative of 4 which on subsequent deacetylation provided a good yield of 5-bromo-4-chloro-7-(β-D-ribo-furanosyl)pyrrolo[2,3-d] pyrimidine ( 6 ). Assignment of the halogen substituent to position 5 was made on the basis of pmr studies. Treatment of 6 with methanolic ammonia afforded 4-amino-5-bromo-7-(β-D-ribofuranosyl)pyrrolo[2,3-d ]pyrimidine ( 8 , 5-bromotubercidin) and a subsequent study has revealed that the 4-chloro group of 6 was replaced preferentially in a series of nucleophilic displacement reactions. The analogous synthesis of 4,5-dichloro-7-(β-D-ribo-furanosyl)pyrrolo[2,3-d]pyrimidine ( 13b ) and 4-chloro-5-iodo-7-(β-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine ( 13a ) from 4 furnished 5-chlorotubercidin ( 15 ) and 5-iodotubercidin ( 14 ), respectively, on treatment of 13b and 13a with methanolic ammonia. The possible biochemical significance of these tubercidin derivatives is discussed.     

Novel pyrrolo[2,3-d]pyrimidine derivatives as multi-kinase inhibitors with VEGFR-2 selectivity

Since the discovery of imatinib, the first tyrosine kinase inhibitor, in 2001, targeted therapy has become mainstream of cancer therapeutics. Despite the advantages in efficacy and low side effects compared with conventional chemotherapy, the success of the targeted anticancer drugs is still limited by the drug resistance which happens due to the fact that the development of cancer is stimulated by several stimuli and therefore, defeating cancer may occur upon the inhibition of several targets. However, coadministration of multiple drugs always lead to many disadvantages including increased toxicity and less patient compliance. Therefore, the aim of research is to develop anticancer agents with multi-target action based on the modification of the chemical structure of sunitinib, a well-known multi-kinase inhibitor. A series of fifteen compounds comprising pyrrolo[2,3-d]pyrimidine and hydrazone have been designed and successfully synthesized. Among the synthesized compounds, compounds 6f, 6l and 6n inhibited the enzymatic activity of EGFR, Her2, VEGFR-2 and CDK2 kinase enzymes similar to sunitinib and the reference protein kinase inhibitors. Interestingly, remarkable results were revealed by compounds 6j and 6c that demonstrated selective VEGFR-2 inhibition activities and compound 6i that exhibited selective dual inhibition of Her2/VEGFR-2 enzymes. Further analysis revealed that compounds 6f and 6n suppressed cell cycle progression of HepG2 cells and induced early and late apoptosis. Moreover, those two compounds triggered a significant elevation in caspase 3 and Bax proapoptotic proteins and a notable reduction in Bcl-2 anti-apoptotic protein. Finally, molecular docking studies were conducted to predict the possible binding interactions of 6f and 6n with CDK2 and 6f, 6n, 6j and 6c with VEGFR-2.     

Synthesis,anticancer and antimicrobiological activities of pyrrolo[2,3-d]pyrimidines

Reactions of 6-amino-3,4-dihydro-2-methoxy-4-oxopyrimidine 1a and its 3-methyl derivative 1b with chloroacetaldehyde and chloroacetyl chloride are discussed in this paper. Amongst others compounds, we have obtained, in low yield, the novel ring system oxazolo[3,2-c]pyrrolo[3,2-e]pyrimidine. The anticancer and antimicrobial activities of some of the obtained products are described.     

Syntheses of substituted pyrrolo[2,3-d]imidazoles

Starting from the readily available 5-hydroxymethyl-2-mercapto-1-methylimidazole (1) substituted pyrrolo[2,3-d]imidazoles were prepared.     

Pyrrolopyridazines. 1. Synthesis and reactivity of pyrrolo[2,3-d]pyridazine 5-oxides

Reaction of ethyl 4-ethoxymethyleneamino-3-methoxy-5-pyridazinylpyruvate 1-oxide ( 8 ) under various conditions constitutes a new approach to substituted pyrrolo[2,3-d]pyridazines. The resulting substituted pyrrolo[2,3-d]pyridazine 5-oxides were allowed to react further to provide a number of new compounds in this ring system.     

Synthesis and photophysical properties of oligoarylenes with a pyrrolo[2,3-d]pyrimidine core

The palladium-catalyzed Suzuki-Miyaura reaction of 2,4-dichloropyrrolo[2,3-d]pyrimidine with aryl boronic acids has been studied. Pd(OAc)₂/dicyclohexyl(2-biphenyl)phosphine/K₃PO₄ was found to be an efficient catalyst system to prepare 4-aryl-2-chloro- and 2,4-diarylpyrrolo[2,3-d]pyrimidines. Novel non-linear molecules consisting of a pyrrolo[2,3-d]pyrimidine core and aryl branches have been elucidated as blue light-emitters with fluorescence quantum yields ranging from 4% to 67% in THF solution. The impact of an electron-withdrawing t-BuOCO group attached to the pyrrole ring of pyrrolopyrimidine derivatives on optical properties is discussed.     

The syntheses and properties of tricyclic pyrrolo[2,3-d]pyrimidine analogues of S6-methylthioguanine and O6-methylguanine

The syntheses of novel tricyclic pyrrolo[2,3-d]pyrimidine analogues of S6-methylthioguanine are described. The crystal structures and pKa values of these and related O6-methylguanine analogues are reported. All compounds display higher pKa values than O6-methylguanine with the sulfur-containing analogues being the more basic and exhibiting higher stability in aqueous solution. In a standard substrate assay with the human repair protein O6-methylguanine-DNA methyltransferase (MGMT) only the oxygen-containing analogue displayed activity.